News & Events
Read more VitroScan @ESGO Congress 2026 – Meet us in Copenhagen! 🌍
12 February 2026
We’re delighted to share that Willemijn Vader, VitroScan’s CEO, together with Michelle Meijer, member of our Project Steering Committee, will be attending the ESGO 2026 Congress in Copenhagen.
Read more
Read more Meet VitroScan at BioEurope Spring 2026
9 February 2026
Exciting news! VitroScan will be at BioEuropeSpring (March 23‑25, Lisbon). We’d love to connect and discuss how our ex vivo micro‑tumor testing can accelerate the development of your oncology assets.
Read more
Read more Biotech Booster Annual Event 2026 on March 10: Willemijn Vader and Joris Schuurmans will present ChemoPredict project journey
5 February 2026
Join Willemijn Vader, CEO at VitroScan, and Joris Schuurmans, Chair of the ChemoPredict project steering committee, at the Biotech Booster Annual Event on March 10.
Read more
Read more VitroScan at DxPx 2026
26 January 2026
Meet VitroScan at the DxPx conference, 5-6 February in Munich! Our CEO Willemijn Vader will represent VitroScan and will be available for in person meetings.
Read more
Read more VitroScan featured in Oncologie Up-to-date magazine
6 January 2026
VitroScan, known for its ex vivo 3D micro-tumor testing platform, has been highlighted in the latest issue of Oncologie Up-to-date, the Dutch medical scientific news magazine that reports on current developments in oncology .
Read more
Read more Meet VitroScan!
1 November 2025
In this video, Willemijn Vader explains how our ChemoPredict platform supports better treatment decisions.
Read more
Read more VitroScan will be pitching at the Dutch Life Sciences Day investors forum
31 October 2025
Meet VitroScan at the Dutch Life Sciences Conference 2025 where Willemijn Vader will be pitching at the investors forum.
Read more
Read more VitroScan awarded Kansen voor West grant to advance ex vivo tumor testing for next-generation immunotherapies
29 October 2025
VitroScan awarded 'Kansen voor West'-grant to advance ex vivo tumor testing for next-generation immunotherapies
Read more
Read more VitroScan is presenting at SITC 2025
15 October 2025
VitroScan will be presenting at the 40th Anniversary Annual Meeting of the Society of Immunology of Cancer.
Read more
Read more VitroScan will be present at Bio-Europe 2025
1 October 2025
VitroScan will be present and available to discuss how our testing solutions can help you reduce risk and maximize success in your drug development process.
Read more
Read more VitroScan's micro-tumor test accurately predicts chemotherapy response for ovarian cancer patients
9 September 2025
VitroScan is proud to announce the publication of a study showing its 3D ex vivo micro-tumor testing platform can accurately predict whether an ovarian cancer patient will respond to chemotherapy.
Read more
Read more VitroScan awarded ~ 200k Leap Medical:Forge grant
22 April 2025
We are very pleased to announce that VitroScan has received a grant of approximately 200k Euros from leap:up. The grant is part of the medical:forge Leipzig accelerator program, based in Leipzig, Germany.
Read more